Stay updated on Emricasan for Decompensated NASH Cirrhosis Clinical Trial

Sign up to get notified when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays Revision: v3.4.3 and no longer shows Revision: v3.4.2; this is a metadata update that does not change study details.
    Difference
    0.0%
    Check dated 2026-03-11T15:21:40.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The changes are administrative in nature: a new site revision tag (v3.4.2) and removal of an outdated funding notice, with no impact on the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:34:10.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-02-03T23:46:22.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Show glossary is now displayed, new labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' were added, and a revision note 'Revision: v3.4.0' was introduced. Deletions adjust wording to 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' and remove the older 'Revision: v3.3.4' label; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-27T21:52:32.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new Locations section was added, listing study sites by state (Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington). The previous per-state location blocks were removed.
    Difference
    2%
    Check dated 2025-12-23T09:13:30.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision: v3.3.2; no substantive changes to study details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:08:24.000Z thumbnail image

Stay in the know with updates to Emricasan for Decompensated NASH Cirrhosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.